AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/117
SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/
Authors: AGHI M KRAMM CM CHOU TC BREAKEFIELD XO CHIOCCA EA
Citation: M. Aghi et al., SYNERGISTIC ANTICANCER EFFECTS OF GANCICLOVIR THYMIDINE KINASE AND 5-FLUOROCYTOSINE/CYTOSINE DEAMINASE GENE THERAPIES/, Journal of the National Cancer Institute, 90(5), 1998, pp. 370-380
TARGETING GENE-THERAPY VECTORS TO CNS MALIGNANCIES
Authors: SPEAR MA HERRLINGER U RAINOV N PECHAN P WEISSLEDER R BREAKEFIELD XO
Citation: Ma. Spear et al., TARGETING GENE-THERAPY VECTORS TO CNS MALIGNANCIES, Journal of neurovirology, 4(2), 1998, pp. 133-147
NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/
Authors: RAINOV NG DOBBERSTEIN KU SENAESTEVES M HERRLINGER U KRAMM CM PHILPOT RM HILTON J CHIOCCA EA BREAKEFIELD XO
Citation: Ng. Rainov et al., NEW PRODRUG ACTIVATION GENE-THERAPY FOR CANCER USING CYTOCHROME-P450 4B1 AND 2-AMINOANTHRACENE 4-IPOMEANOL/, Human gene therapy, 9(9), 1998, pp. 1261-1273
PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR
Authors: HERRLINGER U KRAMM CM ABOODYGUTERMAN KS SILVER JS IKEDA K JOHNSTON KM PECHAN PA BARTH RF FINKELSTEIN D CHIOCCA EA LOUIS DN BREAKEFIELD XO
Citation: U. Herrlinger et al., PREEXISTING HERPES-SIMPLEX VIRUS-1 (HSV-1) IMMUNITY DECREASES, BUT DOES NOT ABOLISH, GENE-TRANSFER TO EXPERIMENTAL BRAIN-TUMORS BY A HSV-1 VECTOR, Gene therapy, 5(6), 1998, pp. 809-819
DE-NOVO MUTATIONS (GAG DELETION) IN THE DYT1 GENE IN 2 NON-JEWISH PATIENTS WITH EARLY-ONSET DYSTONIA
Authors: KLEIN C BRIN MF DELEON D LIMBORSKA SA IVANOVASMOLENSKAYA IA BRESSMAN SB FRIEDMAN A MARKOVA ED RISCH NJ BREAKEFIELD XO OZELIUS LJ
Citation: C. Klein et al., DE-NOVO MUTATIONS (GAG DELETION) IN THE DYT1 GENE IN 2 NON-JEWISH PATIENTS WITH EARLY-ONSET DYSTONIA, Human molecular genetics (Print), 7(7), 1998, pp. 1133-1136
LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR
Authors: RAINOV NG DOBBERSTEIN KU HEIDECKE V DORANT U CHASE M KRAMM CM CHIOCCA EA BREAKEFIELD XO
Citation: Ng. Rainov et al., LONG-TERM SURVIVAL IN A RODENT BRAIN-TUMOR MODEL BY BRADYKININ-ENHANCED INTRAARTERIAL DELIVERY OF A THERAPEUTIC HERPES-SIMPLEX VIRUS VECTOR, Cancer gene therapy, 5(3), 1998, pp. 158-162
EXCLUSION OF CHROMOSOME REGIONS 6P12 AND 15Q11, BUT NOT CHROMOSOME REGION 7P11, IN A GERMAN FAMILY WITH AUTOSOMAL-DOMINANT CONGENITAL NYSTAGMUS
Authors: KLEIN C VIEREGGE P HEIDE W KEMPER B HAGEDORNGREIWE M HAGENAH J VOLLMER C BREAKEFIELD XO KOMPF D OZELIUS L
Citation: C. Klein et al., EXCLUSION OF CHROMOSOME REGIONS 6P12 AND 15Q11, BUT NOT CHROMOSOME REGION 7P11, IN A GERMAN FAMILY WITH AUTOSOMAL-DOMINANT CONGENITAL NYSTAGMUS, Genomics (San Diego, Calif.), 54(1), 1998, pp. 176-177
CLINICAL AND GENETIC EVALUATION OF A FAMILY WITH A MIXED DYSTONIA PHENOTYPE FROM SOUTH TYROL
Authors: KLEIN C PRAMSTALLER PP CASTELLAN CC BREAKEFIELD XO KRAMER PL OZELIUS LJ
Citation: C. Klein et al., CLINICAL AND GENETIC EVALUATION OF A FAMILY WITH A MIXED DYSTONIA PHENOTYPE FROM SOUTH TYROL, Annals of neurology, 44(3), 1998, pp. 394-398
EXPRESSION OF THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) IN HUMAN BRAIN
Authors: AUGOOD SJ PENNEY JB FRIBERG IK BREAKEFIELD XO YOUNG AB OZELIUS LJ STANDAERT DG
Citation: Sj. Augood et al., EXPRESSION OF THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) IN HUMAN BRAIN, Annals of neurology, 43(5), 1998, pp. 669-673
ARE MAO-A DEFICIENCY STATES IN THE GENERAL-POPULATION AND IN PUTATIVEHIGH-RISK POPULATIONS HIGHLY UNCOMMON
Authors: MURPHY DL SIMS K EISENHOFER G GREENBERG BD GEORGE T BERLIN F ZAMETKIN A ERNST M BREAKEFIELD XO
Citation: Dl. Murphy et al., ARE MAO-A DEFICIENCY STATES IN THE GENERAL-POPULATION AND IN PUTATIVEHIGH-RISK POPULATIONS HIGHLY UNCOMMON, Journal of neural transmission. Supplementum, (52), 1998, pp. 29-38
THE USE OF RABBIT CYTOCHROME-P450 4B1 AS NEW PRODRUG ACTIVATOR FOR GENE-THERAPY OF HEPATOCELLULAR-CARCINOMA
Authors: MOHR L RAINOV N MOHR U BREAKEFIELD XO WANDS JR
Citation: L. Mohr et al., THE USE OF RABBIT CYTOCHROME-P450 4B1 AS NEW PRODRUG ACTIVATOR FOR GENE-THERAPY OF HEPATOCELLULAR-CARCINOMA, Hepatology, 28(4), 1998, pp. 1425-1425
MONITORING HSV-1-TK AND LACZ GENE DELIVERY AND COEXPRESSION BY A REPLICATION-CONDITIONAL HSV-1 VECTOR IN 9L GLIOSARCOMA CELLS - IMPLICATIONS FOR THERAPEUTIC GENE IMAGING IN-VIVO
Authors: JACOBS A TJUVAJEV JG JOSHI R HERRLINGER U BALATONI J FINN R BREAKEFIELD XO BLASBERG RG
Citation: A. Jacobs et al., MONITORING HSV-1-TK AND LACZ GENE DELIVERY AND COEXPRESSION BY A REPLICATION-CONDITIONAL HSV-1 VECTOR IN 9L GLIOSARCOMA CELLS - IMPLICATIONS FOR THERAPEUTIC GENE IMAGING IN-VIVO, The Journal of nuclear medicine, 39(5), 1998, pp. 1042-1042
CLINICAL AND GENETIC-CHARACTERIZATION OF A FAMILY FROM SOUTH TYROL (NORTHERN ITALY) WITH AN UNUSUAL PRESENTATION OF DYSTONIA
Authors: PRAMSTALLER PP KLEIN C CASTELLAN C BREAKEFIELD XO OZELIUS LJ
Citation: Pp. Pramstaller et al., CLINICAL AND GENETIC-CHARACTERIZATION OF A FAMILY FROM SOUTH TYROL (NORTHERN ITALY) WITH AN UNUSUAL PRESENTATION OF DYSTONIA, Neurology, 50(4), 1998, pp. 2027-2027
A GENETIC-STUDY OF 72 PATIENTS WITH IDIOPATHIC FOCAL DYSTONIA FROM NORTHERN GERMANY
Authors: KLEIN C VIEREGGE P HAGENAH J RISCH NJ BREAKEFIELD XO OZELIUS LJ
Citation: C. Klein et al., A GENETIC-STUDY OF 72 PATIENTS WITH IDIOPATHIC FOCAL DYSTONIA FROM NORTHERN GERMANY, Neurology, 50(4), 1998, pp. 2098-2098
A DE-NOVO MUTATION (GAG DELETION) IN THE DYT1 GENE IN A PATIENT OF MENNONITE ORIGIN
Authors: OZELIUS LJ KLEIN C DELEON D BREAKEFIELD XO BRESSMAN SB
Citation: Lj. Ozelius et al., A DE-NOVO MUTATION (GAG DELETION) IN THE DYT1 GENE IN A PATIENT OF MENNONITE ORIGIN, Neurology, 50(4), 1998, pp. 2103-2103
QUANTITATIVE KINETICS OF HSV-1-TK GENE DELIVERY TO TUMOR-CELLS USING A RECOMBINANT HSV-1 VECTOR - IMPLICATIONS FOR IMAGING HSV-1 MEDIATED GENE-TRANSFER IN-VIVO
Authors: JACOBS AH TJUVAJEV JG JOSHI A JOSHI R HERRLINGER U BALATONI J FINN R BREAKEFIELD XO BLASBERG RG
Citation: Ah. Jacobs et al., QUANTITATIVE KINETICS OF HSV-1-TK GENE DELIVERY TO TUMOR-CELLS USING A RECOMBINANT HSV-1 VECTOR - IMPLICATIONS FOR IMAGING HSV-1 MEDIATED GENE-TRANSFER IN-VIVO, Neurology, 50(4), 1998, pp. 5028-5028
HSV-1 VECTORS ALLOW EFFICIENT TRANSFER OF THE RYR1 CDNA INTO DYSPEDICSKELETAL-MUSCLE CELLS
Authors: FRAEFEL C WINGROVE D MOORE R PESSAH IN BREAKEFIELD XO ALLEN PD
Citation: C. Fraefel et al., HSV-1 VECTORS ALLOW EFFICIENT TRANSFER OF THE RYR1 CDNA INTO DYSPEDICSKELETAL-MUSCLE CELLS, Biophysical journal, 74(2), 1998, pp. 142-142
BENEFITS AND RISKS OF HOSTING ANIMAL-CELLS IN THE HUMAN BRAIN
Authors: ISACSON O BREAKEFIELD XO
Citation: O. Isacson et Xo. Breakefield, BENEFITS AND RISKS OF HOSTING ANIMAL-CELLS IN THE HUMAN BRAIN, Nature medicine, 3(9), 1997, pp. 964-969
GENE-TRANSFER INTO HEPATOCYTES MEDIATED BY HELPER VIRUS-FREE HSV AAV HYBRID VECTORS/
Authors: FRAEFEL C JACOBY DR LAGE C HILDERBRAND H CHOU JY ALT FW BREAKEFIELD XO MAJZOUB JA
Citation: C. Fraefel et al., GENE-TRANSFER INTO HEPATOCYTES MEDIATED BY HELPER VIRUS-FREE HSV AAV HYBRID VECTORS/, Molecular medicine, 3(12), 1997, pp. 813-825
THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP BINDING-PROTEIN
Authors: OZELIUS LJ HEWETT JW PAGE CE BRESSMAN SB KRAMER PL SHALISH C DELEON D BRIN MF RAYMOND D COREY DP FAHN S RISCH NJ BUCKLER AJ GUSELLA JF BREAKEFIELD XO
Citation: Lj. Ozelius et al., THE EARLY-ONSET TORSION DYSTONIA GENE (DYT1) ENCODES AN ATP BINDING-PROTEIN, Nature genetics, 17(1), 1997, pp. 40-48
FINE LOCALIZATION OF THE TORSION DYSTONIA GENE (DYT1) ON HUMAN-CHROMOSOME 9Q34 - YAC MAP AND LINKAGE DISEQUILIBRIUM
Authors: OZELIUS LJ HEWETT J KRAMER P BRESSMAN SB SHALISH C DELEON D RUTTER M RISCH N BRIN MF MARKOVA ED LIMBORSKA SA IVANOVASMOLENSKAYA IA MCCORMICK MK FAHN S BUCKLER AJ GUSELLA JF BREAKEFIELD XO
Citation: Lj. Ozelius et al., FINE LOCALIZATION OF THE TORSION DYSTONIA GENE (DYT1) ON HUMAN-CHROMOSOME 9Q34 - YAC MAP AND LINKAGE DISEQUILIBRIUM, PCR methods and applications, 7(5), 1997, pp. 483-494
GENE-THERAPY FOR METASTATIC BRAIN-TUMORS BY VACCINATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED TUMOR-CELLS
Authors: YU JS BURWICK JA DRANOFF G BREAKEFIELD XO
Citation: Js. Yu et al., GENE-THERAPY FOR METASTATIC BRAIN-TUMORS BY VACCINATION WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-TRANSDUCED TUMOR-CELLS, Human gene therapy, 8(9), 1997, pp. 1065-1072
HSV AAV HYBRID AMPLICON VECTORS EXTEND TRANSGENE EXPRESSION IN HUMAN GLIOMA-CELLS/
Authors: JOHNSTON KM JACOBY D PECHAN PA FRAEFEL C BORGHESANI P SCHUBACK D DUNN RJ SMITH FI BREAKEFIELD XO
Citation: Km. Johnston et al., HSV AAV HYBRID AMPLICON VECTORS EXTEND TRANSGENE EXPRESSION IN HUMAN GLIOMA-CELLS/, Human gene therapy, 8(3), 1997, pp. 359-370
THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY
Authors: KRAMM CM CHASE M HERRLINGER U JACOBS A PECHAN PA RAINOV NG SENAESTEVES M AGHI M BARNETT FH CHIOCCA EA BREAKEFIELD XO
Citation: Cm. Kramm et al., THERAPEUTIC EFFICIENCY AND SAFETY OF A 2ND-GENERATION REPLICATION-CONDITIONAL HSV1 VECTOR FOR BRAIN-TUMOR GENE-THERAPY, Human gene therapy, 8(17), 1997, pp. 2057-2068
HYBRID VECTORS - A NEW-GENERATION OF VIRUS-BASED VECTORS DESIGNED TO CONTROL THE CELLULAR FATE OF DELIVERED GENES
Authors: JACOBY DR FRAEFEL C BREAKEFIELD XO
Citation: Dr. Jacoby et al., HYBRID VECTORS - A NEW-GENERATION OF VIRUS-BASED VECTORS DESIGNED TO CONTROL THE CELLULAR FATE OF DELIVERED GENES, Gene therapy, 4(12), 1997, pp. 1281-1283
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>